NYSE · STE
STERIS plc (Ireland)
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for STE: Nov 04, 2026
STERIS plc (Ireland) Ordinary Shares is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $2.67. The reported EPS for the same quarter last year was $2.47.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $2.67 | $2.68 | $2.66 | 2 |
| Dec 2026 | $2.81 | $2.81 | $2.80 | 2 |
| Mar 2027 | $3.15 | $3.19 | $3.12 | 2 |
| Jun 2027 | $2.86 | $2.86 | $2.86 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · BNK Invest · RTTNews · MarketBeat- Zacks · Oct 29, 7:43 AM EDT2 Healthcare Technology Stocks for a Digital Health BoomGMED and STE offer exposure to healthcare technology growth, with projected 2026 EPS gains, attractive valuations and innovations in essential medical services.
- Zacks · Oct 16, 7:14 AM EDTReasons to Add STE Stock to Your Portfolio Right NowSTERIS' strong Healthcare growth, improving AST prospects and rising Life Sciences demand bolster its outlook, despite tariff and inflationary pressures.
- BNK Invest · Oct 14, 4:42 PM EDTOmnicom Group Now #371 Largest Company, Surpassing STERISIn the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Omnicom Group, Inc. (Symbol: OMC) has taken over the #371 spot from STERIS plc (Symbol: STE), according to The Online Investor. Market capitalization is an important
- RTTNews · Oct 12, 4:00 PM EDTXodus Medical Agrees To Be Acquired By STERIS(RTTNews) – Xodus Medical, a developer and manufacturer of surgical safety products, has agreed to be acquired by STERIS (STE), a provider of healthcare products and services focused on infection prevention.
- Zacks · Sep 4, 11:30 AM EDTSteris (STE) Down 2.1% Since Last Earnings Report: Can It Rebound?Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- BNK Invest · Sep 3, 10:19 AM EDTSTE Ex-Dividend Reminder – 9/4/26Looking at the universe of stocks we cover at Dividend Channel, on 9/4/26, STERIS plc (Symbol: STE) will trade ex-dividend, for its quarterly dividend of $0.69, payable on 9/25/26. As a percentage of STE's recent stock price of $231.59, this dividend works out to approximately
- Zacks · Aug 21, 12:01 PM EDTCan STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.
- Zacks · Aug 20, 10:46 AM EDTShould Investors Buy STERIS as Growth Meets Reasonable Valuation?STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.
- Zacks · Aug 18, 2:24 PM EDTEcolab Rallies 12.2% in 3 Months as High-Tech Growth Gains MomentumECL's 12.2% three-month rally is backed by High-Tech, Digital and Life Sciences growth, firmer pricing and a higher 2026 earnings outlook.
- MarketBeat · Aug 9, 4:03 AM EDTSTERIS Q1 Earnings Call HighlightsSTERIS (NYSE:STE) reported first-quarter fiscal 2027 revenue growth and higher earnings, while maintaining its full-year outlook and outlining a $600 million investment in a new chemistry manufacturing, research and distribution complex in North Carolina. Total reported revenue
- BNK Invest · Aug 7, 7:03 PM EDTSTE Crosses Above Key Moving Average LevelIn trading on Friday, shares of STERIS plc (Symbol: STE) crossed above their 200 day moving average of $234.41, changing hands as high as $237.44 per share. STERIS plc shares are currently trading up about 2.3% on the day. The chart below shows the one year performance of STE
- Zacks · Aug 6, 11:03 AM EDTSTE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket TradingSTERIS beats fiscal Q1 earnings estimates as sales rise 7.3%, but a modest revenue miss sends shares 2.4% lower after hours.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for STERIS plc (Ireland) from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.